JPRN-UMIN000028773招募中未知
Development of the infants given tadalafil treatment in utero.
Mie university hospital, Department of Obstetrics and Gynecology0 个研究点目标入组 20 人开始时间: 2017年8月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18months-old 至 21months-old（—）
- 性别
- All
入选标准
- •Written informed consent
排除标准
- •Attending physician decides to entry inappropriate.
研究者
相似试验
已完成
1 期
Tadalafil treatment for Fetus with Early onset growth Restrictiofetal growth restrictionJPRN-UMIN000020044Department of Obstetrics & Gynecology Mie University Faculty of Medicine12
招募中
2 期
Tadalafil for fetus with early-onset growth restriction (TADAFER IIb)Fetal growth restrictionFetal growth restriction, PDE5 inhibitorJPRN-jRCTs041190065Maki Shintaro180
已完成
不适用
Tadalafil study for pediatric PAH on efficacy, safety and pharmacodynamicspediatric pulmonary arterial hypertensionJPRN-UMIN000005973ational Cerebral and Cardiovascular Center10
进行中（未招募）
1 期
Extremely low gestational age infants' PARAcetamol StudyOpen ductus arteriosus of a premature infantEUCTR2018-000566-11-FIniversity of Oulu40
进行中（未招募）
1 期
A study in children with Pulmonary Arterial Hypertension to assess the safety of Tadalafil as the dose increases, as well as how the drug works in the bodyPulmonary Arterial HypertensionEUCTR2011-001873-24-ESEli Lilly and Company19